The rapid growth of high-deductible health plans (HDHP) has been driven in part owing to a belief that cost-sharing obligations (ie, having skin in the game) will encourage health insurance enrollees to shop for health care. 1 The wide variation in costs across physicians and hospitals implies considerable opportunity for enrollees to save money by switching to lowercost providers. 2 High-deductible health plan enrollment is associated with lower health care spending. 3, 4 However, prior studies using health insurance claims data indicate these savings are primarily owing to decreased use of care and not because HDHP enrollees are switching to lower-cost providers. 5 Limited prior work has assessed attitudes toward price shopping among HDHP enrollees and whether they were more likely to consider costs when seeking care.
Methods | We surveyed a nationally representative sample of insured US adults between 18 and 64 years of age who used medical care in the last year and compared HDHP enrollees with people in traditional plans on rates of shopping for care. The sample was drawn from GfK's online KnowledgePanel (http: //www.knowledgenetworks.com/ganp/), generated through a probability-based random sampling of adults and teens recruited via address-based sampling. Those enrolled in the study were then provided Internet access at no cost. The definition of an HDHP was established as a health plan having an individual deductible greater than $1250 or a family deductible greater than $2500 6 or a health plan that included a health savings account. All analyses were weighted by poststratification weights to be representative of US enrollees in HDHP and non-HDHP plans. We surveyed enrollees for their attitudes about price shopping, and whether, when they most recently received medical care, enrollees considered going to see another health care professional or if out-of-pocket costs were compared between different health care providers. We used logistic regression to compare enrollees in HDHPs and non-HDHPs, accounting for sociodemographic characteristics.
Results | The response rate was 67.6%, and the study sample included 1951 respondents: 1099 in the HDHP group and 852 in the non-HDHP group. High-deductible health plan enrollment was higher among whites, those employed, those with more education, and those with higher income (Table 1) . Overall, 659 of 1099 HDHP enrollees (60%) believe there are large differences in prices and in quality across health care providers, only 185 (17%) think higher price physicians provide higher quality care, and 774 (71%) report that out-ofpocket costs are important when choosing a doctor ( Table 2) . These perceptions are not significantly different from those held by enrollees in traditional plans. We found that HDHP enrollees are less likely to believe that higher price facilities provide higher quality care than non-HDHP enrollees (n = 179 [16%] vs n = 206 [25%]; P = .001) and more likely to report out-of-pocket costs are important in choice of radiology facility (n = 882 [81%] vs n = 598 [74%]; P = .003) than enrollees in traditional plan. A total of 611 HDHP enrollees (56%) say they would use additional sources of health care price information if available.
During their last use of medical care, HDHP enrollees were no more likely than enrollees in traditional plans to consider going to another health care professional for their care (n = 120 [10.9%] vs n = 85 [10.0%]; P = .67), or to compare out-ofpocket cost differences across health care professionals (n = 42 [3.8%] vs n = 23 [2.7%]; P = .37).
Discussion | Simply increasing a deductible, which gives enrollees skin in the game, appears insufficient to facilitate price shopping. Members of HDHP and traditional plans are equally likely to price shop for medical care, and they hold similar attitudes about health care prices and quality. Despite considerable focus on increasing price transparency, 1 HDHP enrollees express interest in greater access to health care price information.
Key limitations of our study are that we did not survey the uninsured or enrollees who did not use medical care. Because respondents report care-seeking behavior up to 12 months prior, recall bias may be an issue. We lack information about enrollee use of quality information. Despite a high level of response, there may be potential bias owing to differences between respondents and nonrespondents.
If encouraging price shopping is a viewed as an important policy goal, then there is a need for greater availability of price information and innovative approaches to enrollee engagement with this information. Black, non-Hispanic 78 (7) 96 (12) Other 80 (7) 60 (7) Hispanic 76 (7) 119 (15) Household income, US$, % ≤30 000 80 (7) 133 (16) <.001 30 000-60 000 265 (24) 198 (24) 60 000-100 000 283 (26) 175 (21) >100 000 474 (43) High-deductible health plans-insurance plans that have lower premiums but higher deductibles than traditional health plans-have been increasingly promoted as a means to incentivize higher-value health care decision making. However, we have little information on how individuals take accessibility, cost, and quality information into account when making health care decisions. Moreover, there remains uncertainty about whether individuals will obtain recommended health care services while at risk for greater out-of-pocket costs.
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In this issue of JAMA Internal Medicine, Sinaiko and colleagues 3 conduct an internet-based survey of enrollees in high-deductible health plans and traditional health plans to better understand how they think about health care decisions. Individuals enrolled in plans with different financial incentives actually share many of the same beliefs about health care pricing and how to obtain high-quality care. Both rarely consider obtaining care from a different health care professional and even less often compare costs among health care professionals. Despite the limitations of an internet-based sample and few questions to disentangle the nuance of decision making, an interpretation of this study could be that highdeductible health plans are rationally designed for individuals who do not yet have access to sufficient information to make higher-value decisions in today's market, suggesting that these plans have not yet succeeded at making cost and quality information more available and more actionable for their enrollees. However, a more likely interpretation is that getting enrollees to make higher-value decisions remains a mirage. Highdeductible health plans take advantage of an irrationally designed health care system. In fact, information about our health care system is asymmetric in that it is better understood by physicians and less so by patients, which means patients obtaining care are not truly informed decision makers.
It is true that high-deductible health plan enrollees have "skin in the game." However, these enrollees are exposed to substantial out-of-pocket cost risk with little evidence that this risk exposure will incentivize higher-value health care deci- Methods | The project was a multifaceted medical education campaign managed by a group of senior physicians (including D.B.-H., A.Y., and J.K.), with continuous and systematic monitoring and feedback. The group met monthly to discuss issues from the practice of internal medicine with a content expert and Intel engineers (V.B. and N.G.) who volunteered as part of a nationwide community involvement program. At the end of each meeting, the forum wrote up a set of recommendations that were communicated to all physicians in the Division of Internal Medicine through various channels. The impact of the initiative was continuously measured by quantifiable data related to blood and imaging tests, and a defined set of measurements was reported to the staff as monthly feedback. The need for study approval was waived by the institutional review board of the Rambam Health Care Campus.
Results | Various topics were discussed during 2014, and a set of recommendations for common laboratory tests and other diagnostic tests was compiled by the forum. For example, we agreed that measurement of B-type natriuretic peptide levels as part of the workup for acute dyspnea should not be included in cases with an unequivocal diagnosis of acute left heart failure or with a more likely alternative diagnosis. 2 Proper use of troponin level measurement in the workup of patients presenting with chest pain and recommendations for avoiding unnecessary repeated testing represented another example. Use of both tests was significantly reduced (Figure 1 ). Another issue discussed by our forum was routine (and unnecessary) blood tests. We found that unbundling panel chemistry tests reduced the use of routine measurement of lactic dehydrogenase, creatine kinase, and amylase levels by more than 50% (Figure 2 ). The number of tests ordered for Creactive protein, hemoglobin A 1c , and thyrotropin levels was also significantly reduced. During the first year of the project, we achieved a 20% reduction in the total number of laboratory tests performed, resulting in a savings of $250 000. In addition, the laboratory turnaround time from sample receipt to results dispatch was reduced.
Discussion | We have presented an example of successful development of a method for the use of diagnostic tools for a specific topic list, inspired by the US Choosing Wisely campaign, 1 in an individual hospital. Our initiative was implemented through an educational model that included systematic monitoring and feedback. Although the selected topics may not be generalizable beyond the scope of our division's practice, the guiding principles of the method can be applied in other settings. In recent years, many studies dealing with costeffectiveness and reduction of low-value health care activities by different types of interventions have been published. [3] [4] [5] [6] However, several elements make our initiative unique. First, our recommendations are based on thorough discussion of the 
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Recommendations were released in March 2014 for measurement of BNP levels in the workup of acute dyspnea and of troponin levels in the workup of acute chest pain. Use of both tests declined significantly (P < .001).
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